Newly Diagnosed Type 2 Diabetes Clinical Trial
Official title:
Induction of Long-term Glycemic Remission Via Structured Simplified Short-term Intensive Insulin Therapy in Patients With Newly Diagnosed Type 2 Diabetes: a Multiple Centered, Randomised Controlled Trial.
Short-term intensive insulin therapy is shown to induced glycemic remission, but traditionally patients were hospitalized for 2-4 weeks in order to receive the therapy, the long inpatient period precluded the wide application of the thrapy. This study aims to invesitgate whether simplified regimen is non-inferior to traditional regimen in achieving long-term glycemic remisson.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04271189 -
Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03832725 -
Pathobiology of Remission of Type 2 Diabetes
|
N/A | |
| Completed |
NCT02506582 -
The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control
|
N/A | |
| Completed |
NCT01863147 -
Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01895387 -
Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes
|
N/A |